Jakavi 15
Drug Category |
|
Medicinal form |
Tablets |
Active ingredient |
|
Concentration |
15mg |
Manufacturer |
|
Price |
36545 EGP |
Uses
is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases. For the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea and for the treatment of diseaserelated splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idio pathic myelofibrosis), post polycythemia vera myelofi
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies